Application of next‐generation sequencing to improve cancer management: A review of the clinical effectiveness and cost‐effectiveness
Owen Tan(The University of Sydney), Deborah Schofield(The University of Sydney), Michelle Cunich(Macquarie University), Rupendra Shrestha(Macquarie University)
Cited by 107
Related Papers
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
|International Journal of Obesity|2012|2.1k
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions
|JAMA Pediatrics|2017|335
Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement
|Genetics in Medicine|2017|246
Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders
|Genetics in Medicine|2018|200
Chronic disease and labour force participation among older Australians
|The Medical Journal of Australia|2008|189